Bristol-Myers Squibb Reports Strong Fourth Quarter Sales, But Gains Minimized By Write-Offs
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm’s short-term investment portfolio dinged by shaky fourth-quarter securities market.